26th -
27th
March 2025
March 2025 | 
Hilton Taipei Sinban, Taiwan

11 Years of Innovation: Taiwan’s ONLY Biologics, Vaccines & Stem Cells Summit

26th -
27th
March 2025 | 
Hilton Taipei Sinban, Taiwan
📆 Add to Google Calendar
Attendees
0 +
Companies
0 +
Speakers
0 +
In-Person Networking Hours
0 +
Case Studies
0 +

Since its inception in 2012, Biologics World Taiwan has experienced remarkable success by gathering over 300 pioneers in the biologics industry from Taiwan and around the world. Dedicated to fostering the development and manufacturing of high-quality biologic drugs, vaccines, stem cells, and regenerative medicines in Taiwan for the global market, Biologics World Taiwan 2025 is poised to continue its impactful legacy.

This year's conference will delve into a spectrum of pivotal topics, including must-see innovations originating from Taiwan, best practices in clinical research and trials, optimization of upstream processing, cost reduction in downstream processes, advancements in CAR-T and stem cell therapy, compelling case studies in regenerative medicines, and more. The agenda promises the most comprehensive coverage of Taiwan's biologics development and manufacturing landscape.

By participating in the conference, attendees will have the opportunity to engage with key and emerging entities within Taiwan's Biologics and Vaccine space, including distinguished organizations such as PharmaEssentia, Eirgenix, Mycenax, Medigen Biotechnology Corp, Lumosa Therapeutics, and others. If Taiwan stands out as a region rich in opportunities within the bio-manufacturing, vaccine, and cell therapy sectors, then Biologics World Taiwan 2025 is the definitive event to attend.

Discover the latest developments in Taiwan's biologics manufacturing sector, spanning from current best R&D practices to the trajectory towards advanced manufacturing. Immerse yourself in recent, exclusive case studies and gain insights into the industry's key needs—all under one roof! Don't miss this opportunity to stay at the forefront of Taiwan's dynamic biologics landscape.

FEATURED CONTENT

eBook Thumbnail
Taiwan's Top 123 Biopharma Innovators for 2025: A Biopharma & CDMO Directory
booming-banner
Taiwan's Booming Biopharma: Biologics and Regenerative Medicines Pipeline
Survey Infographic - Taiwan's Challenges and Opportunities in Biologics Development
Survey Infographic - Taiwan's Challenges and Opportunities in Biologics Development
Untitled-design-19-1024x1024
Biologics World Taiwan Attendee List 2023
Untitled-design-10-1024x1024
Why Global Giants Are Betting Big on Taiwan
new-ebook-cover-1024x1024
Empowering Biologics Innovation, The Future Begins Here
MicrosoftTeams-image-2022-09-22T125547.419
Taiwan's Cell & Gene Therapy Landscape
ebook-cover-page-1024x1024
Emerging Taiwan Biologics Industry Now and Future 2022
cover photo
Biologics World Taiwan 2023 Post Event Report
Untitled design (5)
Exploring Taiwan's Biotechnology Hubs
Taiwan’s Leading Biopharma
Taiwan’s Leading Biopharma in Phase 3 Clinical Pipelines
12th Biologics World Taiwan 2025

Explore the best practices of clinical development & trials with the ultimate goal of bringing new biologics products with proven therapeutic effect to the market. Learn how important the transition of preclinical research to clinical stages can mark a critical turning point of new biologics development.

Process optimization is the key success factor to develop biomanufacturing practices with high productivity and reduced cost. Immerse in the latest technology from Taiwan about the key practices to enhance productivity and speed in producing biologics.

The emerging CMO leaders from Taiwan are about to share their success stories with valuable insights and case studies to deliver the next generation manufacturing capabilities that Taiwan is providing to the world in making first class biologics products that can save millions of lives.

Antibody and Protein therapeutics are emerging as the most promising class of diagnostics to treat diseases in humans. Innovative sharing and case studies of effective antibody and protein treatments will be shared by the experts.

Innovative strategy of assay optimization, real time monitoring system with highest compromisation to quality control of biologics products to a direction of improving efficiency while advocating process automation are the keys to quicker market commercialization and regulatory compliance. Topics built around cost and process optimization with latest developments in analytics and quality to foster biologics enhancement.

Gain insights on the latest case studies of stem cell and regenerative medicine and recognize the potential of the cell and gene therapies.

Explore the latest CAR-T cell therapy advancements with impressive and effective solutions for antitumor treatments, especially against hematological malignancies from Taiwan’s key leaders in the CAR-T cell therapy industry.

Immerse in the best practices of cell & gene therapy products from the innovative showcase of the Taiwan market while considering the key factors and strategy that can lead to successful scale up and manufacturing of the products.

Listen to the key industry leaders of cell & gene therapy about their success stories of making the commercialization of the products a successful ones while replicating the strategies of effective manufacturing and commercialization in the market.

THANK YOU TO OUR SUPPORTING PARTNERS









12th Biologics World Taiwan 2025

Past Speakers

Abigail Pittman

Special Assistant to the CEO

PELL BIO-MED TECHNOLOGY
Taiwan

Albert Yueh-Peng Hung,

Deputy Chief Operating Officer, Adimmune Corp, Taiwan

Alex Blyth

CEO, LIft Biosciences, UK

UK

Austin Tsai

Assistant Vice President,

Maria Von
Taiwan

Cheng-Han Tsai

CEO, Cytena, Taiwan

Cheng-Yi Jerry Kuo

Vice General Manager,

UWELL BioPharma
Taiwan

ChiaChu Tsai

Co-Founding Partner, COO, CellTech Innovation Studio Co., Taiwan

Dar-Jen Hsieh

CEO, ACRO Biomedical Co., Ltd.

Taiwan

Donggeon Kim

DVM, Ph.D. Principal Scientist Kanaph therapeutics, S Korea

Hem Reddy

Director of APAC Business Development,

Pfanstiehl Inc.
USA

Jan Mou Lee

Founder & Scientific Advisor, Fullhope Biomedical Co., Ltd

Taiwan

Jason Huang M.D ; J.D.

CEO/CMO of ASCENDO Biotech

Taiwan

Julio Lin

Vice President

Blue Blood Biotech
Taiwan

Karen Wen, Ph.D.

COO and Chief Strategy Officer, GenomeFrontier Therapeutics, Inc

Taiwan

Kevin Chih-Yuan Ho

Director of Clinical Department, Steminent Biotherapeutics Inc.

Taiwan

Li-Ming Lu

Senior Clinical Project Manager, ARCE Therapeutics, Taiwan

Pearl Fong

Development Manager, Eirgenix, Taiwan

Shugene Lynn

CEO and President, United BioPharma

Vatsala Sadasivan

Global Operational Excellence Lead- R&D, Sanofi

Verena Tan Wan Ying

Product Specialist, Chromatography

APAC Sartorius
Taiwan

Yan-Jye Shyong

Assistant Professor, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University

Taiwan

Yen Choo

Founder & Chairman, Assoc. Professor of Stem Cell Science and Regenerative Medicine

Plasticell Ltd, Lee Kong Chian School of Medicine
Singapore

Yun-Chi Lu

PhD., Chief Executive Officer, PrecisemAb Biotech, Taiwan

2025

SPEAKERS

Featuring esteemed voices from the biopharmaceutical sector. Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders. Don't miss this chance to broaden your understanding of this ever-evolving industry.

Aprilia Paramitasari

Medical Doctor

Taipei Medical University
Taiwan

Charles Hou

Director of Biologics Research & Development

Holy Stone Healthcare
Taiwan

Cheng-Yi Jerry Kuo

Vice General Manager,

UWELL BioPharma
Taiwan

Chi-Jung Liang

Manager, R&D Department

UnicoCell Biomed Co., Ltd.
Taiwan

Chiao-Wen Chen

Executive Director, Institute of Drug Evaluation Platform

Development Center for Biotechnology
Taiwan

Chih-Kai Hsu

Director of Mitochondria Process Development

Taiwan Mitochondrion Application Technology Co., Ltd,
Taiwan

Chuang Simon Shih-Hsien

Chief Executive Officer

HoneyBear Biosciences
Taiwan

Dr. Ping-Yang Yeh

President

Altrubio Taiwan
Taiwan

Dr. Wan-Fen Li

Development Champion, Development Team

OBI Pharma
Taiwan

Dr. Wen Chyi Shyu

Chief Executive Officer

BRIM Biotechnology
Taiwan

Dr. Yu-Hsiang Chang

Chief Executive Officer & Chief Medical Officer

Locus Cell
Taiwan

Eric Tang

Chairman & General Manager

Lukas Biomedical
Taiwan

Jen-Chih Chi

Director of Cell Therapy CMC

BeiGene
Taiwan

Jih-Hung Guo

Manager of Cell Line Process Development

Mycenax
Taiwan

Juine-Ruey Chen

Chief Operating Officer

RuenHuei Biopharma
Taiwan

Julio Lin

Vice President

Blue Blood Biotech
Taiwan

Kuo-Hsiang Chuang

Chief Executive Officer

CytoArm
Taiwan

Kwang Joon Yoon

Managing Director and Head of Business Planning Department Cell and Gene Therapy CDMO

Matica BIOLABS
South Korea

Min-Shi Lee

Investigator, National Institute of Infectious Diseases and Vaccinology, National Health Research Institute, Co-Founder

Taiwan Universe Biomedicine (Tai-U)
Taiwan

Vivian Kuo

Senior Director CMC,

HanchorBio,
Taiwan

William Hung, Ph.D.

Assistant General Manager, Maria Von

Taiwan

Xiaotong Song

PhD, Associate Professor, Translational Medical Science Department, School of Medicines Texas A&M University

Founding CEO of Cellula Biopharma
USA

DELEGATE REGISTRATION

APAC Biopharma / Academic
SGD 1,695

LIMITED SPECIAL (until 29th November 2024)

*THIS PRICING IS APPLICABLE TO:

Company Profiles: Biopharma, BIG Pharmas, Academic & Research Institutes in Taiwan and APAC

Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.

NON-APAC Biopharma / Academic
SGD 2,195

LIMITED SPECIAL (until 29th November 2024)

*THIS PRICING IS APPLICABLE TO:

Company Profiles: International Biopharma, BIG Pharmas, Academic & Research Institutes outside APAC

Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.

Service or Solution Provider
SGD 3,195

LIMITED SPECIAL (Until 29th November 2024)

*SOLUTION PROVIDER PRICING IS APPLICABLE TO:

Company Profile: Technology and Solutions Provider, Asian/International Biopharma, BIG Pharmas, CMO’s, CRO's, Asian Academic/Research Institutes.

Job Profiles: Business Development, Marketing & Sales

DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

APAC Biopharma / Academic
SGD 1,695

LIMITED SPECIAL (until 29th November 2024)

*THIS PRICING IS APPLICABLE TO:

Company Profiles: Biopharma, BIG Pharmas, Academic & Research Institutes in Taiwan and APAC

Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.

NON-APAC Biopharma / Academic
SGD 2,195

LIMITED SPECIAL (until 29th November 2024)

*THIS PRICING IS APPLICABLE TO:

Company Profiles: International Biopharma, BIG Pharmas, Academic & Research Institutes outside APAC

Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.

Service or Solution Provider
SGD 3,195

LIMITED SPECIAL (Until 29th November 2024)

*SOLUTION PROVIDER PRICING IS APPLICABLE TO:

Company Profile: Technology and Solutions Provider, Asian/International Biopharma, BIG Pharmas, CMO’s, CRO's, Asian Academic/Research Institutes.

Job Profiles: Business Development, Marketing & Sales

Taiwan Biopharma Excellence Awards 2025

 6:00 PM – 7:30 PM

26th March 2025

FEATURED CONTENT

eBook Thumbnail
Taiwan's Top 123 Biopharma Innovators for 2025: A Biopharma & CDMO Directory
booming-banner
Taiwan's Booming Biopharma: Biologics and Regenerative Medicines Pipeline
Survey Infographic - Taiwan's Challenges and Opportunities in Biologics Development
Survey Infographic - Taiwan's Challenges and Opportunities in Biologics Development
Untitled-design-19-1024x1024
Biologics World Taiwan Attendee List 2023
Untitled-design-10-1024x1024
Why Global Giants Are Betting Big on Taiwan
new-ebook-cover-1024x1024
Empowering Biologics Innovation, The Future Begins Here
MicrosoftTeams-image-2022-09-22T125547.419
Taiwan's Cell & Gene Therapy Landscape
ebook-cover-page-1024x1024
Emerging Taiwan Biologics Industry Now and Future 2022
cover photo
Biologics World Taiwan 2023 Post Event Report
Untitled design (5)
Exploring Taiwan's Biotechnology Hubs
Taiwan’s Leading Biopharma
Taiwan’s Leading Biopharma in Phase 3 Clinical Pipelines

#BUZZ ABOUT THE EVENT

SIMILAR EVENTS

Register Now. SAVE BIG!

Download Post Event Report Form

Download Participating Companies

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Attendee List

Download Prospectus Document Form

Brochure Form

Sponsorship Form

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Agenda Form

Apply For Speaking Opportunity

Featured Content Form

Download List of Biopharma Companies in Asia Brochure

Download Ebook

Download Ebook

VWSEA2024 Brochure

Download List of Biopharma, CMO, CRO, CDMO and Big Pharma in China and Taiwan Brochure

Download Strategic Consulting Brochure

Download Case Study Consulting Digital Disruption

Download Case Study Consulting Revolutionizing Biopharmaceuticals

Download IMAPAC Custom Events Prospectus

Download Case Study : Fill-Finish Solution provider increasing its market share

Download Case Study : European CMO expanding into APAC

Download Case Study : China CDMO's New Gene Protein Facility Opening

Download Biologics Newsletter

Download Cell and Gene Therapy Newsletter

Download Vaccines Newsletter

Download 1:1 Networking Meetings Case Study- High-end assembly solutions provider

Download 1:1 Networking Meetings Case Study- IT/Software Solution provider

Download 1:1 Networking Meetings Case Study

Download Ebook

Download Ebook

Download Events Calendar

Customised Webinar/Webcast

Download Customised Events Brochure

Contact us for Third Party Email Services

Download Newsletter Press Kit

Download Network Meetings Prospectus

Download Media Kit

Download Form

Cell and Gene Therapy World Summit Brochure

    Contact Form


    IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

    Download Brochure Sample

      Contact Form


      IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.